GlobeNewswire: AngioDynamics Contains the last 10 of 175 releaseshttp://www.globenewswire.com/External?Length=42024-03-29T10:35:15ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2017/09/28/1134215/0/en/AngioDynamics-Reports-Fiscal-2018-First-Quarter-Results.html?f=22&fvtc=4&fvtv=13169AngioDynamics Reports Fiscal 2018 First Quarter Results2017-09-28T10:00:00Z<![CDATA[ALBANY, N.Y., Sept. 28, 2017 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today reported first quarter financial results for the 2018 fiscal year ended August 31, 2017.]]>https://www.globenewswire.com/news-release/2017/09/14/1121066/0/en/Outcomes-in-a-Nurse-Led-Peripherally-Inserted-Central-Catheter-Program-A-Retrospective-Cohort-Study-Published-in-CMAJ-Open.html?f=22&fvtc=4&fvtv=13169Outcomes in a Nurse-Led Peripherally Inserted Central Catheter Program: A Retrospective Cohort Study Published in CMAJ Open2017-09-14T11:00:00Z<![CDATA[Low rates of major PICC-associated complications attributed in-part to the novel BioFlo catheter material]]>https://www.globenewswire.com/news-release/2017/09/14/1121038/0/en/AngioDynamics-to-Report-Fiscal-2018-First-Quarter-Financial-Results.html?f=22&fvtc=4&fvtv=13169AngioDynamics to Report Fiscal 2018 First Quarter Financial Results2017-09-14T10:00:00Z<![CDATA[ALBANY, N.Y., Sept. 14, 2017 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report financial results for its fiscal 2018 first quarter ended August 31, 2017, on Thursday, September 28, 2017, before the open of the U.S. financial markets.]]>https://www.globenewswire.com/news-release/2017/09/13/1120190/0/en/AngioDynamics-to-Present-at-the-2017-Cantor-Fitzgerald-Global-Healthcare-Conference.html?f=22&fvtc=4&fvtv=13169AngioDynamics to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference2017-09-13T10:00:00Z<![CDATA[ALBANY, N.Y., Sept. 13, 2017 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Michael C. Greiner, Executive Vice President and Chief Financial Officer, is scheduled to present at the 2017 Cantor Fitzgerald Healthcare Conference on Monday, September 25, 2017, at 8:35 a.m. EDT. The conference will be held at the InterContinental New York Barclay in New York City.]]>https://www.globenewswire.com/news-release/2017/08/29/1101616/0/en/AngioDynamics-to-Present-at-the-2017-Morgan-Stanley-Global-Healthcare-Conference.html?f=22&fvtc=4&fvtv=13169AngioDynamics to Present at the 2017 Morgan Stanley Global Healthcare Conference2017-08-29T10:00:00Z<![CDATA[ALBANY, N.Y., Aug. 29, 2017 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Jim Clemmer, President and Chief Executive Officer and Michael C. Greiner, Executive Vice President and Chief Financial Officer, are scheduled to participate in a fireside chat at the 2017 Morgan Stanley Global Healthcare Conference on Monday, September 11, 2017, at 2:50 p.m. EDT. The conference will be held at the Grand Hyatt in New York City.]]>https://www.globenewswire.com/news-release/2017/08/07/1081009/0/en/AngioDynamics-to-Present-at-the-2017-Canaccord-Genuity-Growth-Conference.html?f=22&fvtc=4&fvtv=13169AngioDynamics to Present at the 2017 Canaccord Genuity Growth Conference 2017-08-07T11:48:41Z<![CDATA[ALBANY, N.Y., Aug. 07, 2017 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Michael Greiner, Executive Vice President and Chief Financial Officer, is scheduled to present and participate in a fireside chat at the Canaccord Genuity Growth Conference on Thursday, August 10, 2017, at 11:00 a.m. ET. The conference will be held at the InterContinental in Boston, MA.]]>https://www.globenewswire.com/news-release/2017/07/18/1047745/0/en/AngioDynamics-Reports-Fiscal-2017-Fourth-Quarter-and-Full-Year-Results.html?f=22&fvtc=4&fvtv=13169AngioDynamics Reports Fiscal 2017 Fourth Quarter and Full-Year Results2017-07-18T10:00:00Z<![CDATA[Company posts record full-year adjusted EPS and Free Cash Flow and issues FY2018 Financial Guidance]]>https://www.globenewswire.com/news-release/2017/07/07/1041360/0/en/AngioDynamics-to-Report-Fiscal-2017-Fourth-Quarter-and-Full-Year-Financial-Results.html?f=22&fvtc=4&fvtv=13169AngioDynamics to Report Fiscal 2017 Fourth Quarter and Full-Year Financial Results2017-07-07T10:00:00Z<![CDATA[ALBANY, N.Y., July 07, 2017 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report financial results for its fiscal 2017 fourth quarter and full-year ended May 31, 2017, on Tuesday, July 18, 2017, before the open of the U.S. financial markets.]]>https://www.globenewswire.com/news-release/2017/06/07/1009231/0/en/AngioDynamics-Announces-FDA-Clearance-for-The-Solero-Microwave-Tissue-Ablation-System.html?f=22&fvtc=4&fvtv=13169AngioDynamics Announces FDA Clearance for The Solero Microwave Tissue Ablation System2017-06-07T10:00:00Z<![CDATA[ALBANY, N.Y., June 07, 2017 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease and oncology/surgery, today announced the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Solero Microwave Tissue Ablation (MTA) System. The Solero MTA System and Accessories are indicated for the ablation of soft tissue during open procedures. The Solero MTA System is not intended for cardiac use.]]>https://www.globenewswire.com/news-release/2017/05/31/1003838/0/en/AngioDynamics-Lawsuit-Alleges-C-R-Bard-is-Violating-Antitrust-Laws-Harming-Competition-and-Limiting-Access.html?f=22&fvtc=4&fvtv=13169AngioDynamics Lawsuit Alleges C.R. Bard is Violating Antitrust Laws, Harming Competition and Limiting Access2017-05-31T10:00:00Z<![CDATA[ALBANY, N.Y., May 31, 2017 (GLOBE NEWSWIRE) -- C.R. Bard has illegally tied the sale of its tip location systems to its line of peripherally inserted central catheters (“PICCs”), violating federal antitrust laws, preventing competition in the marketplace and limiting patient access to superior technology, according to a lawsuit filed today by AngioDynamics (NASDAQ:ANGO). AngioDynamics, a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, filed the lawsuit in the U.S. District Court for the Northern District of New York.]]>